Givaudan | GIVN - Operating Expenses


Givaudan reported CHF3B in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Air Liquide EUR 10.93B 561.2M Jun/2026
Akzo Nobel EUR 2.61B 273M Sep/2026
Anheuser-Busch USD 11.97B 82M Sep/2026
Arkema EUR 2.24B 139.2M Jun/2026
Associated British Foods GBP 9.34B 491M Dec/2026
BASF EUR 16.49B 719M Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Beiersdorf EUR 4.19B 32M Jun/2026
British American Tobacco GBP 7.6B 942M Jun/2026
Covestro EUR 3.24B 5.46B Dec/2025
Croda International GBP 699.2M 350.7M Dec/2024
Danone EUR 12.08B 396M Jun/2026
Diageo GBP 7.2B 807M Dec/2025
Fresenius EUR 5.24B 19M Sep/2026
Fresenius Medical Care EUR 4.55B 229.7M Sep/2026
Givaudan CHF 3B 107M Dec/2025
Heineken EUR 10.69B 1.91B Jun/2026
Henkel EUR 8.7B 35M Jun/2026
International Flavors Fragrances USD 13.26B 717M Sep/2026
Johnson Matthey GBP 7.02B 1.81B Jun/2026
Kerry EUR 2.94B 355.5M Jun/2026
Lonza CHF 2.9B 184M Jun/2025
L'Oréal EUR 18.71B 1.05B Jun/2026
Merck EUR 4.34B 249M Jun/2026
Nestle CHF 36.13B 2.29B Jun/2026
Pernod Ricard EUR 3.64B 174M Dec/2025
Reckitt Benckiser GBP 6.26B 3.51B Dec/2024
SGS CHF 1.48B 16.5M Dec/2024
Sika AG CHF 4.8B 78.3M Dec/2025
Solvay EUR 1.07B 44M Jun/2026
Tate & Lyle GBP 962M 90M Dec/2026
Umicore EUR 27.12B 17.15B Jun/2026
Victrex GBP 128.1M 4.2M Jun/2026